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b Department of Experimental and Clinical Medical Sciences (DISM), University of Udine, Udine, ItalyThe brain's ability to maintain function in the presence of an incipi- by linear effects at the level of regional activity and functional coupling,
ent or ongoing detrimental neural condition is well-recognized (Grady,
2008). In neurodegenerative diseases, such neural mechanisms may be
able to counteract progressive pathology, at least until theminimumca-
pacity which is needed until cognitive and sensorimotor performance
falls below a critical threshold. Such mechanisms have been often re-
ferred to as “compensatory” and may involve neural activity increases
in brain regions normally recruited during a task, reconﬁguration of
functional coupling or recruitment of alternative neural pathways. In
neuropsychiatric diseases, identifying neural mechanisms as “compen-
satory” – and not just as aberrant patterns of brain function – is of
outstanding relevance. If neuroimaging should be used as a technique
for identifying, validating and implementing biological markers, then
any measurable deviation of brain activity will need to be classiﬁed
not only as “abnormal” but also with respect to its functional conse-
quences, i.e. whether they may be detrimental or beneﬁcial for thought
and behavior. If compensatory mechanisms are at play then in an inter-
ventional trial designed to delay the onset or progression of a disease, a
speciﬁc intervention may not want to disrupt neural compensation. In
such a case, promoting compensation is one of the primary goals.
Huntington's disease (HD) in many ways is a neuropsychiatric
“model disease” (Ross and Tabrizi, 2011). The availability of genetic
testing allows an identiﬁcation of persons who carry the HTT-gene
mutation but who will remain presymptomatic for several decades
(preHD). In these individuals functional magnetic resonance imaging
(MRI) has been shown to be sensitive to neural dysfunction in situations
where atrophy can be hardly detected by standard structural neuroim-
aging. Klöppel and colleagues for the ﬁrst time explicitly investigate
potential compensatory mechanisms in preHD (Klöppel et al., 2015).
The essential advance for future research is that compensation was
not addressed post-hoc or discussed among other plausible explana-
tions. The authors employ a speciﬁc statistical model which takes into
account task performance, structural disease load and neural activity.
The assumption is that higher structural disease burden is accompaniedDOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.002.
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maintaining task performance. In our view, there is a strong teleological
component underlying this assumption, but at the same time this is a
prerequisite if one wants to avoid speculations on what activity change
actually reﬂects. An important point of results is the biological plausibil-
ity of their ﬁndings: the role of the parietal and dorsolateral prefrontal
cortices in working memory neurobiology is well established
(Gazzaley and Nobre, 2012). But this is just the tip of the iceberg,
since the Track-On HD data set yields additional and invaluable infor-
mation potential. Further analysis strategies may shed light on more
complex (e.g. nonlinear) interactions between resting-state and task-
based functional connectivity, brain volume and cognitive/motor
requirements.
The study by Klöppel and colleagues can decisively shape future
functional neuroimaging research in HD and other neurodegenerative
conditions, but we believe that there is much more to learn from this
study. The rationale and design should also motivate psychiatric re-
search,where there is still an urgent need of valid and reliable biological
markers. In depression or schizophrenia, for example, where cognitive
deﬁcits are prominent and deleterious for clinical outcome, there has
been substantial effort tomap neural correlates of cognitive dysfunction
and to deﬁne neural predictors of treatment response (Fu et al., 2013;
Ramsay and MacDonald, 2015). In both depression and schizophrenia,
there is a long-standing debate if regionally increased activity is reﬂec-
tive of neural compensation, whether this may be efﬁcient or not
(Callicott et al., 2003). Surprisingly, there have been only a few attempts
to integrate structural data into the functional data analyses (Sui et al.,
2012; Vasic et al., 2015). At multiple levels of biology and symptom ex-
pression there are clear differences between depression/schizophrenia
and HD. But there is a loss of brain volume over time in both depression
and schizophrenia, as much as there is evidence for compensatory neu-
ral activity which is so far unexplained in terms of its underlying neuro-
biology. Functional changes could be primary in the sense that they are
intrinsic to the disorder and not secondary to structural alterations.
Alternatively, functional compensation for structural damage is a possi-
ble explanation (as much as other explanations may be plausible as
well, such as compensation for aberrant neural transmission), yet this
possibility has not been addressed so far in a theoretically convincingthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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by Klöppel and colleagues may foster integrative neuroimaging
approaches using explicit models of neural compensation at various
levels of model complexity. Clearly, in depression and schizophrenia
genetic and environmental inﬂuences need to be considered (although
recent data suggest that the very same applies to HD; Mo et al., 2015),
and any “close-to-real-world” compensation model in these disorders
will seek to account for these variables in advanced stages of research.
But before doing so, why not start with the obvious, especially when
the available neuroimaging data invites and justiﬁes such an approach.
In this sense, this paper paves theway for an innovative path that opens
up novel avenues of research not only for neurodegeneration but also
for several other mental disorders.
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